Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Matthew Kase"'
Autor:
Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. De La Vega, Yonglan Zheng, Toshio F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. Howard, Rita Nanda, Nike Beaubier, Kevin P. White, Dezheng Huo, Olufunmilayo I. Olopade
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-13 (2023)
Abstract Background Endocrine-resistant HR+/HER2- breast cancer (BC) and triple-negative BC (TNBC) are of interest for molecularly informed treatment due to their aggressive natures and limited treatment profiles. Patients of African Ancestry (AA) ex
Externí odkaz:
https://doaj.org/article/006ca307fd264a2eaf4c46f5adf6c1f6
Autor:
Gary A. Palmer, Caroline G. Epstein, Michael D. Axelson, Michael E. Salazar, Matthew Kase, Martin C. Stumpe, Calvin McCarter, Ashraf T. Hafez, Joyce O'Shaughnessy, Alexandria M. Bobe, Benjamin D. Leibowitz, Ameen A. Salahudeen, Joshua S.K. Bell, Nike Beaubier, Catherine Igartua, Robert Huether, Mark D. Pegram, Louis E. Fernandes, Ruth A. Pe Benito, Sarah Sammons
Publikováno v:
Clinical Breast Cancer. 21:e340-e361
Objective/Background We performed a retrospective analysis of longitudinal real-world data (RWD) from patients with breast cancer to replicate results from clinical studies and demonstrate the feasibility of generating real-world evidence. We also as
Autor:
Yinjie, Gao, Michelle M, Stein, Matthew, Kase, Amy L, Cummings, Ramit, Bharanikumar, Denise, Lau, Edward B, Garon, Sandip P, Patel
Publikováno v:
Cancer immunology, immunotherapy : CII.
Adjuvant immune checkpoint blockade (ICB) following chemoradiotherapy and adding ICB to chemotherapy have been key advances for stages III-IV non-small cell lung cancer (NSCLC) treatment. However, known biomarkers like PD-L1 are not consistently indi
Autor:
Minetta C. Liu, Matthew MacKay, Matthew Kase, Aneta Piwowarczyk, Christine Lo, Jeff Schaeffer, Justin D. Finkle, Christopher E. Mason, Nike Beaubier, Kimberly L. Blackwell, Ben Ho Park
Publikováno v:
JCO precision oncology. 6(1)
PURPOSE Tissue-based next-generation sequencing (NGS) in metastatic breast cancer (mBC) is limited by the inability to noninvasively track tumor evolution. Cell-free DNA (cfDNA) NGS has made sequential testing feasible; however, the relationship betw
Autor:
Nike Beaubier, Matthew Kase, Ameen A. Salahudeen, Martin C. Stumpe, Louis E. Fernandes, Ruth A. Pe Benito, Joshua S.K. Bell, Alexandria M. Bobe, Caroline G. Epstein, Michael D. Axelson, Gary A. Palmer, Catherine Igartua, Calvin McCarter, Michael E. Salazar, Joyce O'Shaughnessy, Robert Huether, Mark D. Pegram, Sarah Sammons, Ashraf T. Hafez, Benjamin D. Leibowitz
INTRODUCTIONWe performed a retrospective analysis of longitudinal real-world data (RWD) from breast cancer patients to replicate results from clinical studies and demonstrate the feasibility of generating real-world evidence. We also assessed the val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a83cb92f2552fe3ec5cabdebe607431
https://doi.org/10.1101/2020.08.07.20168401
https://doi.org/10.1101/2020.08.07.20168401
Autor:
Matthew Kase
Publikováno v:
Making and Using Antibodies: A Practical Handbook, Second Edition
Antibodies protect us from a wide range of infectious diseases and cancers and have become an indispensable tool in science-both for conventional immune response research as well as other areas related to protein identification analysis. This second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff4a8a8fa9d6540276eb9f984173359d
https://doi.org/10.1201/b15103
https://doi.org/10.1201/b15103